Rare diseases
Investigational molecules
Locations
237 conditions with trials, the busiest first
741 trials across Europe, recruiting first
Study of Retatrutide for Patients with Obesity, Overweight, and Chronic Low Back Pain
PolandStudy on the Effects of AGA2118 for Postmenopausal Women with Osteoporosis
BulgariaStudy on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3
BelgiumStudy on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease
BelgiumStudy of Plozasiran for Adults with Severe Hypertriglyceridemia
BelgiumStudy Comparing MAB-22 and Denosumab for Treating Osteoporosis in Postmenopausal Women
BulgariaStudy to Evaluate Plozasiran for Adults with High Triglycerides
BulgariaStudy on the Effects of Semaglutide on Diabetic Eye Disease in People with Type 2 Diabetes
BulgariaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
AustriaStudy of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression
AustriaStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
AustriaStudy on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4
BelgiumThe therapies tested most often in Metabolism and nutrition disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
